ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

Allergy. 2021 Mar;76(3):689-697. doi: 10.1111/all.14471. Epub 2020 Sep 21.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2 / physiology
  • Asthma / complications*
  • Asthma / drug therapy
  • COVID-19 / etiology*
  • Humans
  • SARS-CoV-2*

Substances

  • Angiotensin-Converting Enzyme 2

Grant support